Global Artificial Organs and Bionics Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Product, Technology, Fixation Type & Region – Industry Forecasts (2024 to 2029)

Updated On: June, 2024
ID: 1579
Pages: 175

Artificial Organs and Bionics Market Size (2023 to 2028)

As per our report, the global artificial organs and bionics market size was valued at USD 29.18 Billion in 2023. This value is projected to reach USD 46.13 Billion by 2028, at a CAGR of 9.59% during the forecast period.

Artificial organs are mechanical devices that can temporarily or permanently substitute a body organ. Bionics involves the study of biological systems to develop artificial systems that can replicate their functions. Manufacturers focus on developing bionic implant products such as wearable artificial kidneys, bio-lung, and artificial Pancreas for diseases that cannot be cured with alternative treatment methods.

The artificial organs are for the functioning of the disabled organs made by a human. Bionics is the study of artificial body parts, which are substitutes for ordinary biological competence. The artificial and bionics market plays a significant role in the treatment of organ failures. With the help of these technologies, patients can recover their disabilities, and their organs can perform the activities as before. Bionics and artificial organs can provide for those in need of organ relocations and replacements.


Rising organ failure incidence due to age-related disorders, technological advancements, Y-O-Y growth in the number of injuries leading to organ deletion, and growing preference for organ transplantations are expected to accelerate the global artificial organs and bionics market growth.

According to the Human Resources and Services Administration (HRSA), more than 123,500 people are on the national waiting list in 2020 in the U.S. According to the HRSA report, every 12 minutes, someone is added to the list waiting for transplantation in the United States, increasing the demand for artificial medical devices. There is a high demand for patients who want to do organ transplantation surgery, and the availability of surgeons will drive future market growth.

Due to this wide gap, artificial dynamic organs and the medical bionics market are facing balanced growth. Also, the potential factors which will fuel this market growth are increasing awareness and disposable incomes. However, the factors such as the fear of device breakdown, the risk of compatibility of artificial organs, and their significance, among others, may affect the market growth.

Evolving economies have a new path due to increasing income levels, awareness amongst the people for an organ transplant and high healthcare spending are ascribed to bolster the demand of the market. The deficiency of accessibility of potential organs for transplant has been a significant issue. The need for organ donors is increasing. It is helpful for future demand.


Some factors restraining the growth are the high cost of equipment, surgery, lack of skilled professionals, and undefined compensation policies in some regions. Another factor is the shortage of organs donors. The COVID-19 outbreak has exaggerated economies and industries in many countries due to lockdowns, travel injunctions, and business closures, which are expected to impact market growth negatively.

Impact of COVID-19 on the global artificial organs and bionics market:

The emergence of SARS-COV-2 has affected the Artificial market and bionics market during the initial period of 2020. COVID-19 Has Three Different Effects on the Global Artificial Organs and Bionic Implants Market Economic Breakdown. Affecting production and demand both directly and indirectly. By disrupting the supply chain and the market. With its monetary impact on businesses and financial markets. After the uplift of lockdown across the globe, the demand for organ donors is ever-increasing, and it is very high compared to transplant compared to the actual supply. Bionics and artificial organs can cater to the needs of those in need of organ transplantations and replacements. Many nations are currently concentrating their efforts on a technology that allows for personalized organ and donor eligibility assessment. This tool will assist patients in determining whether to accept donated organs or wait for better possibilities when it comes to organ retrieval. Moreover, the artificial organs and bionics market is estimated to account during the forecast period. 




Market Size Available

2022 to 2028

Base Year


Forecast Period

2023 to 2028

Segments Covered

By Product, Technology, Fixation Type, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa


This research report on the global artificial organs and bionics market has been segmented and sub-segmented based on the product, technology, fixation type, and region.

Artificial Organs and Bionics Market – By Product:

  • Artificial Organs
    • Artificial Heart
    • Artificial Kidney
    • Artificial liver
    • Artificial Pancreas
    • Artificial lungs
  • Bionics
    • Vision bionics
    • Orthopedic bionic
    • Cardiac Bionics
    • Brain bionics

Based on the product, the Artificial Cardiovascular related organs are rooted in the heart, valves, and the other parts based on the artificial organs product type. This innovation is used to link the time to heart transplantation. Total heart transplantation is impossible. 3D bioprint hearts and lab-grown hearts are future research to grow the hearts to attain the lab-made tissues and blood vessels to function smoothly. An artificial kidney prevents blood clotting in the veins. The University of California, San Francisco, developed the artificial kidney in 2018, functioning ideally and can successfully replace the human kidney.

The artificial Pancreas is working to support the pancreatic functions of the patients. The Artificial Liver works as a supportive device to hold the situation, which bridges the patient’s liver functions until a transplant is available. It is done with the help of real liver cells (hepatocytes), but it is not a permanent solution. In Japan, the researchers found that the mixture of human liver predecessor cells induced pluripotent stem cells, and two other cell types can impulsively form 3D structured liver buds. Artificial Lungs are useful to take the substantial weight of the innate lung tissue.

Vision bionics are experimental visual devices used to restore functional vision for those patients based on the bionics product type. Those are suffering from partial or total blindness. Orthopedic bionics are designed to restore remote functionality to the physically disabled, and bionic limbs substitute prosthetic limbs. Cardiacbionics is a fully functional artificial hearts that were developed with the help of nanotechnology Respirocyte (RBC).

Artificial Organs and Bionics Market – By Technology:

  • Electronic bionics
  • Mechanical bionics

Based on technology, Electronic bionics is the electronic device found in biotechnological engineering to control a particular body part's movement. Mechanical bionics are the auxiliary or improvement of organs or other body parts by mechanical forms. Bionic transplants differ from simple prostheses by representing the original function very carefully or even outstanding.

Artificial Organs and Bionics Market – By Fixation Type:

  • Implantable and Externally-worn
  • Cardiac bionics and Brain bionics

Based on the fixation type, the Implantable and external- worn are implants to fix the organ disabilities; these devices can be connected to the organ from the outside, for example, a cochlear implant, which includes the technology that works to send the sound directly to the hearing nerve. These devices have more demand in the future because of rising accidents and organ disabilities.

Cardiac bionic is a technique of providing an adequate amount of gas for exchange cardiac and respiratory support to a patient whose lungs and heart are unable to work correctly. These bionics are also providing support to the halted native circulation. Increasing heart disease incidents are expected to put the cardiac bionics segment at the top in this segment and contribute solidly to the global artificial organs and bionics market.

Artificial Organs and Bionics Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

In terms of Market Share, the North America Artificial Organs and Bionics Market is the biggest market across the globe, followed by Europe. The artificial organs and bionics market in North America is highly driven due to the increasing population and awareness among the patients and the players regarding healthcare facilities and telemedicine. The market is further boosted by the growing community and knowledge of these new techniques. Also, the players and funding given by the government for the healthcare sector will help the market grow in the forecast period.

The Centers for Disease Control and Prevention, a leading US public health institute, awarded grants for a host of health care initiatives in the region in 2018. Chronic disease and health promotion received recognition of the largest part of resources, with 51.28% and 11.34% of 7,501,307,797 USD. Next came the prevention of HIV / AIDS, viral hepatitis, STIs, and tuberculosis, which received 10.24%, and injury prevention and control with 6.21% of the funds. The growing number of health disorders and the increasing demand for better treatments and preventative measures have led to technological advancements in the medical industry. Due to the increase in personal health care spending in the United States, the health industry in the region is growing rapidly, resulting in the growth of the North American market for bionic and artificial organs.

Personal health expenditure in the country has seen a significant increase over the past decade, from $ 2103 billion in 2009 to $ 3,105 billion in 2019, resulting in an average annual percentage change of 4.8% during this period, according to as reported by the CDC. Hospital spending accounted for the largest share, with 41.3% of total personal health care spending in the United States in 2019. Next are medical and clinical costs, prescription drugs, and dental care, which accounted for 25%, 6%, 12.4%, and 4.7%, respectively. It is estimated that the propensity of the population to spend on this industry in exchange for improved technologies and advanced treatment methods, as well as dental and hospital care, will drive the growth of the North American market for bionic and artificial organs in the North region at the end of 2025.

The Asia Pacific Artificial Organs and Bionics market is projected to grow at the highest CAGR, which is significant due to the increasing aging population and large consumer base, rising government initiatives for enhancing healthcare high disposable income.


Companies leading the Global Artificial Organs and Bionics Market profiled in the report are Orthofix International N.V, Biomet, Inc., Medtronic, Inc., Second Sight Medical Products, Ekso Bionics, , Baxter International, Inc., Abiomed, Inc and Ossur.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1800

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample